Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Addiction. 2017 Sep;112(9):1558-1564. doi: 10.1111/add.13795. Epub 2017 Mar 16.
The full burden of the opioid epidemic on US hospitals has not been described. We aimed to estimate how heroin (HOD) and prescription opioid (POD) overdose-associated admissions, costs, outcomes and patient characteristics have changed from 2001 to 2012.
Retrospective cohort study of hospital admissions from the National Inpatient Sample (NIS).
United States of America.
Hospital admissions in patients aged 18 years or older admitted with a diagnosis of HOD or POD. The NIS sample included 94 492 438 admissions from 2001 to 2012. The final unweighted study sample included 138 610 admissions (POD: 122 147 and HOD: 16 463).
Primary outcomes were rates of admissions per 100 000 people using US Census Bureau annual estimates. Other outcomes included in-patient mortality, hospital length-of-stay, cumulative and mean hospital costs and patient demographics. All analyses were weighted to provide national estimates.
Between 2001 and 2012, an estimated 663 715 POD and HOD admissions occurred nation-wide. HOD admissions increased 0.11 per 100 000 people per year [95% confidence interval (CI) = 0.04, 0.17], while POD admissions increased 1.25 per 100 000 people per year (95% CI = 1.15, 1.34). Total in-patient costs increased by $4.1 million dollars per year (95% CI = 2.7, 5.5) for HOD admissions and by $46.0 million dollars per year (95% CI = 43.1, 48.9) for POD admissions, with an associated increase in hospitalization costs to more than $700 million annually. The adjusted odds of death in the POD group declined modestly per year [odds ratio (OR) = 0.98, 95% CI = 0.97, 0.99], with no difference in HOD mortality or length-of-stay. Patients with POD were older, more likely to be female and more likely to be white compared with HOD patients.
Rates and costs of heroin and prescription opioid overdose related admissions in the United States increased substantially from 2001 to 2012. The rapid and ongoing rise in both numbers of hospitalizations and their costs suggests that the burden of POD may threaten the infrastructure and finances of US hospitals.
美国医院所受阿片类药物泛滥的全面影响尚未被描述。我们旨在评估 2001 年至 2012 年期间海洛因(HOD)和处方类阿片(POD)过量相关入院、费用、结果和患者特征的变化。
国家住院患者样本(NIS)的回顾性队列研究。
美利坚合众国。
年龄在 18 岁或以上的因 HOD 或 POD 诊断入院的患者。NIS 样本包括 2001 年至 2012 年的 94492438 次入院。最终未经加权的研究样本包括 138610 次入院(POD:122147 次,HOD:16463 次)。
主要结果是使用美国人口普查局年度估计数计算每 100000 人入院率。其他结果包括住院死亡率、住院时间、累计和平均住院费用以及患者人口统计学特征。所有分析均经过加权以提供全国估计数。
2001 年至 2012 年间,全国范围内估计有 663715 例 POD 和 HOD 入院。HOD 入院人数每年增加 0.11 例/每 100000 人(95%可信区间[CI]为 0.04,0.17),而 POD 入院人数每年增加 1.25 例/每 100000 人(95%CI 为 1.15,1.34)。HOD 入院的每例患者每年增加住院费用 410 万美元(95%CI 为 270 万美元,550 万美元),POD 入院的每例患者每年增加住院费用 4600 万美元(95%CI 为 4310 万美元,4890 万美元),每年与住院相关的费用增加超过 7 亿美元。POD 组的死亡调整后比值比(OR)每年略有下降(OR = 0.98,95%CI 为 0.97,0.99),HOD 死亡率或住院时间无差异。与 HOD 患者相比,POD 患者年龄更大,更可能为女性,更可能为白人。
2001 年至 2012 年期间,美国海洛因和处方类阿片过量相关入院的比例和费用大幅增加。住院人数及其费用的快速持续增加表明,POD 的负担可能威胁到美国医院的基础设施和财务状况。